BIONDIS
LIVE

Serial Number

88585565

Owner

BYONDIS B.V.

Attorney

E. Anthony Figg

Filing Date

Aug 20, 2019

Add to watchlist:

No watchlists yet
View on USPTO

BIONDIS Trademark

Serial Number: 88585565 • Registration: 6032608

BIONDIS is a trademark filed by BYONDIS B.V. on August 20, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

BYONDIS B.V. (25 trademarks)

MICROWEG 22
6545 CM NIJMEGEN , NL

Entity Type: 16

Synthon Biopharmaceuticals B.V. (19 trademarks)

Microweg 22
CM Nijmegen 6545 , NL

Entity Type: 16

Trademark Details

Filing Date

August 20, 2019

Registration Date

April 14, 2020

Published for Opposition

January 28, 2020

Goods & Services

Biopharmaceutical preparations, substances and compositions, namely, antibacterial substances for medical purposes, medical diagnostic reagents in the nature of antibody-drug conjugates, immuno-oncology compounds in the nature of medicinal preparations for the treatment of infectious diseases and for use in oncology, and compounds for auto-immune diseases, namely, pharmaceutical preparations for the treatment of immune system related diseases and disorders; biopharmaceutical active substances, namely, diagnostic agents, preparations and substances for medical purposes in the nature of antibody-drug conjugates, immuno-oncology compounds, namely, pharmaceutical preparations and substances for the treatment of oncological related diseases and disorders, and compounds for auto-immune diseases, namely, pharmaceutical preparations for the treatment of immune system related diseases and disorders; biological and biochemical drug and cultures for medical use, namely, biological preparations for the treatment of cancer, cultures of microorganisms for medical use, and biological tissue cultures for medical purposes; biopharmaceutical active substances, namely, nutritive substances for microorganism cultures; biopharmaceutical components and ingredients, namely, plant and herb extracts sold as components of medicated cosmetics; orthopedic articles, namely, bone repair paste for use in orthopedic surgery; all of the above excluding for the treatment of neuromuscular diseases and disorders

Providing office functions relating to the registration of pharmaceutical preparations and components and pharmaceutical drugs; providing office functions relating to obtaining pharmaceutical registrations and compiling pharmaceutical registration files; business mediation of commercial transactions for others, mediation of contracts for the purchase and sale of products, and mediation of agreements all in the field of the purchase, sale and licensing of pharmaceutical registrations and pharmaceutical registration files

Surgical and medical devices, apparatus and instruments, namely, surgical instruments and apparatus, surgical devices and instruments, surgical apparatus and instruments, medical instruments for cutting tissue, and medical instrument for performing biopsies, medical fluid injectors, injection device for pharmaceuticals, syringes for medical purposes, disposable syringes for medical purposes; orthopedic articles, namely, orthopedic walkers, orthopedic supports, orthopedic braces and orthopedic cushions; injection apparatus for medical purposes, namely, injection needles and injection instruments with needles

Scientific and technological services and research relating thereto, namely, scientific research, analysis and testing in the fields of antibody-drug conjugates, immuno-oncology compounds and compounds for auto-immune diseases and scientific research related thereto; scientific and technological services relating to obtaining pharmaceutical registrations and compiling pharmaceutical registration files, namely, scientific research in the field of pharmaceuticals for pharmaceutical registration purposes; pharmaceutical research services and pharmaceutical research consultancy services; biomedical research services and biomedical research consultancy; medical research and medical research consultancy; scientific laboratory services in the fields of chemistry and biology, antibody-drug conjugates, immuno-oncology compounds and compounds for auto-immune diseases; scientific laboratory services; product development of pharmaceutical products and ingredients for pharmaceuticals; providing information relating to medical and scientific research in the field of pharmaceutical preparations; providing medical and scientific research information regarding the results of clinical trials for pharmaceutical preparations; quality control of products for others to determine conformity with certification standards; laboratory research, namely, scientific and medical research; laboratory analysis in the field of chemistry and biology as related to pharmaceuticals; product research for the pharmaceutical industry; design of pharmaceuticals for the pharmaceutical industry; product research and development for others; drug discovery services; testing in the context of quality control, namely, material testing and product testing; conducting clinical trials for others in the field of pharmaceutical preparations; quality control for others in the field of pharmaceutical preparations; providing information and data relating product research and developments in the pharmaceutical, biopharmaceutical and medical fields

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Apr 14, 2025 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 21, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Nov 21, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 21, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 21, 2022 REAP
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
May 13, 2020 ASGN
REGISTERED-PRINCIPAL REGISTER
Apr 14, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 28, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jan 28, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 8, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 19, 2019 CNSA
ASSIGNED TO EXAMINER
Dec 12, 2019 DOCK
EXAMINER'S AMENDMENT ENTERED
Dec 11, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 11, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 11, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 11, 2019 CNEA
ASSIGNED TO EXAMINER
Dec 11, 2019 DOCK
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 9, 2019 GNRN
NON-FINAL ACTION E-MAILED
Dec 9, 2019 GNRT
NON-FINAL ACTION WRITTEN
Dec 9, 2019 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 2, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 2, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 29, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 20, 2019 GNRN
NON-FINAL ACTION E-MAILED
Nov 20, 2019 GNRT
NON-FINAL ACTION WRITTEN
Nov 20, 2019 CNRT
ASSIGNED TO EXAMINER
Nov 19, 2019 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Nov 5, 2019 AMPX
ASSIGNED TO LIE
Oct 31, 2019 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Oct 25, 2019 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 5, 2019 NWOS
NEW APPLICATION ENTERED
Aug 23, 2019 NWAP